indian drugmaker
India's Wockhardt to supply COVID-19 vaccines to UK
UK government reserved one fill-and-finish production line at Wockhardt subsidiary in Wrexham, Wales for exclusive use for next 18 months
Cipla to price remdesivir version for COVID-19 under Rs 5,000
Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.
1 of 1